News

STAP Stem Cells: Come and Gone

Last January two articles appeared in Nature announcing a new technique for making pluripotent stem cells from mouse cells. This technique is different from the methods used by Nobel Prize winners, Shinya Yamanako and John Gordon. Their methods required turning … Read More

New Molecule Allows for Increase in Stem Cell Transplants

(Medical Xpress) – Investigators from the Institute for Research in Immunology and Cancer (IRIC) at the Université de Montréal have just published, in the prestigious magazine Science, the announcement of the discovery of a new molecule, the first of its … Read More

Controlling the Transition between Generations

(Phys.org) – Rafal Ciosk and his group at the FMI have identified an important regulator of the transition from germ cell to embryonic cell. LIN-41 prevents the premature onset of embryonic transcription in oocytes poised for embryonic development, thus ensuring … Read More

Novel Drug Targeting Leukemia Cells Enters Clinical Trials

(Medical Xpress) – Researchers at the University of California, San Diego School of Medicine have launched a phase 1 human clinical trial to assess the safety and efficacy of a new monoclonal antibody for patients with chronic lymphocytic leukemia (CLL), … Read More

Japan Stem-Cell Trial Stirs Envy

(Nature) – In this instance, the woman’s vision is unlikely to improve. However, researchers around the world are watching to see whether the cells stop the retina from deteriorating further and whether any side effects develop. Should the woman experience … Read More

Stem Cell Harvesting Methods Used by Sydney Doctor Ralph Bright Untested by Clinical Trials

(ABC.net) – Stem cells are often hailed as a miracle cure, but the nation’s top stem cell scientists are warning that buyers should beware of these sorts of procedures, which are yet to be subjected to clinical trials. Professor of … Read More

Scientists Create Therapy-Grade Stem Cells Using New Cocktail to Reprogram Adult Cells

(Eurekalert) – Now researchers at the Hebrew University of Jerusalem have developed a new cocktail of reprogramming factors that produce high-quality iPSCs. Dr. Yosef Buganim, at the Institute for Medical Research Israel-Canada in the Hebrew University’s Faculty of Medicine, worked … Read More

RSS from Bioethics.com

{
Adult/73
|
Embryonic/0
}